James is a corporate lawyer with over 25 years of experience acting for a wide range of clients. He specialises in public and private M&A and joint ventures whilst also advising on a wide range of other transactions and governance issues. 

He has a particular focus on clients in TMT/Digital, Healthcare, Financial Services and Energy. 

James spent two years developing his technology expertise whilst working in a technology start-up before returning to Addleshaw Goddard in 2018.

He has advised clients such as Capita, Probo Medical, Sy4Security, NatWest, Heineken, Tiscali and The Economist on M&A transactions.


A selection of transactions that James has advised on include:

  • Advising Probo Medical on the acquisition of MIUS International;
  • Advising a global commodities trading business on four joint ventures in the renewable energy sector;
  • Advising Probo Medical on the acquisition of Future Medical;
  • Advising Capita plc on the sale of its employee benefits business to Benefex Financial Solutions;
  • Sy4Security on its acquisition of BAe Systems' cyber security business;
  • Moore Stephens on the sale of its Rulebook software business to Verisk Inc;
  • The Royal Bank of Scotland on the sale of a debt and equity portfolio to Coller/Caird Capital;
  • The Royal Bank of Scotland on the sale of its interest in Cairn Capital to Mediobanca;
  • The acquisition of the Clermont Leisure (UK) by Mayfair Casinos;
  • Alchemy on its acquisition of Hampshire Trust Bank;
  • Heineken on its joint venture in Ivory Coast with CFAO;
  • The Royal Bank of Scotland on the sale of its Global Treasury Funds business to Goldman Sachs;
  • The Economist on the acquisition of TVC;
  • Numerous acquisitions of downstream and midstream oil and gas businesses; and
  • Tiscali on the sale of its UK business to TalkTalk.
  • Joint author of Practical Company Law & Transactions (Sweet & Maxwell)